Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psycho Pharma is a specialized pharmaceutical company based in India that focuses on the neuropsychiatry therapeutic segment. The company operates primarily through a PCD (Propagated Community Distribution) pharma franchise model, providing a comprehensive portfolio of medications for central nervous system (CNS) disorders. Their product range includes generic formulations of anti-psychotics, anti-depressants, anxiolytics, and anti-convulsants designed to treat conditions such as schizophrenia, major depressive disorder, and epilepsy. Psycho Pharma emphasizes quality assurance and adherence to manufacturing standards to serve the growing mental health market in India. The company provides marketing support and distribution rights to its franchise partners, positioning itself as a key player in the regional psychiatric pharmaceutical space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Psycho Pharma.